Myocardial revascularization: the evolution of the STS database and quality measurement for improvement
- 77 Downloads
The Society of Thoracic Surgeons (STS) is a not-for-profit organization dedicated to helping clinicians and researchers provide optimal outcomes for patients undergoing heart, lung, and esophageal surgery. The organization was founded in 1964 and has grown to now include over 7300 members in over 90 countries. The STS created a national database that collects detailed clinical information on patients undergoing adult cardiac, pediatric and congenital cardiac, and general thoracic operations. The data collected are used to produce risk-adjusted, nationally benchmarked performance assessments and feedback; facilitate voluntary public reporting; support quality initiatives; develop evidence-based guidelines; monitor long-term clinical outcomes; track device performance; and promote high-quality research collaboratives.
KeywordsSociety of Thoracic Surgeons Surgery Myocardial revascularization
Compliance with ethical standards
IRB for Human and Animal rights were not required.
Conflict of interest
The authors declare that they have no conflict of interest.
- 9.Vassileva CM, Aranki S, Brennan JM, et al. Evaluation of the society of thoracic surgeons online risk calculator for assessment of risk in patients presenting for aortic valve replacement after prior coronary artery bypass graft: An analysis using the STS Adult Cardiac Surgery Database. Ann. Thorac. Surg. 2015;100:2109–15. https://doi.org/10.1016/j.athoracsur.2015.04.149.CrossRefGoogle Scholar
- 17.Bramer S, van Straten AHM, Soliman Hamad MA, Berreklouw E, Martens EJ, Maessen JG. The impact of preoperative atrial fibrillation on early and late mortality after coronary artery bypass grafting. Eur J Cardio-Thoracic Surg. 2010;38:373–9. https://doi.org/10.1016/j.ejcts.2010.02.017.CrossRefGoogle Scholar
- 28.Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129:S49–73. https://doi.org/10.1161/01.cir.0000437741.48606.98.CrossRefGoogle Scholar
- 30.Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45–I49.Google Scholar
- 37.Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of TIAs and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum. 1999;2:242–5.Google Scholar
- 43.Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002;124:136–45. https://doi.org/10.1067/mtc.2002.122306.CrossRefGoogle Scholar
- 49.Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203.CrossRefGoogle Scholar
- 55.Austin TW, Coles JC, Burnett R, Goldbach M. Aortocoronary bypass procedures and sternotomy infections: A study of antistaphylococcal prophylaxis. Can J Surg. 1980;23:483–5.Google Scholar
- 56.Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148:1238–43. https://doi.org/10.1016/j.jtcvs.2014.06.056.CrossRefGoogle Scholar